The city of Mckinney, Texas, currently has 2 active clinical trials seeking participants for Type 1 Diabetes research studies.
Treatment of Type 1 Diabetes With Anti-OX40L Bispecific With Anti-TNF Activity In a Single Nanobody® Molecule
Recruiting
This is a randomized, placebo-controlled, parallel group, multicenter, double-blind Phase 2a, 2-arm study. The goal of this Phase 2a study is to assess safety and efficacy of SAR442970 in comparison to placebo to preserve β-cell function in participants with recently diagnosed type 1 diabetes (T1D) on insulin therapy. The study design comprises 2 parts: in Part A adult participants (18 to 35 years of age at screening) and in Part B adolescent and young adult participants (age range 12 to 21 ye... Read More
Gender:
ALL
Ages:
Between 12 years and 35 years
Trial Updated:
08/21/2025
Locations: Tekton Research LLC- Site Number : 8400017, McKinney, Texas
Conditions: Type 1 Diabetes Mellitus
A Study of Tirzepatide (LY3298176) Compared With Placebo in Adults With Type 1 Diabetes and Obesity or Overweight
Recruiting
The main purpose of this study is to find out how well and how safely tirzepatide works in adults who have type 1 diabetes and obesity or overweight. Participation in the study will last about 49 weeks.
Gender:
ALL
Ages:
18 years and above
Trial Updated:
07/17/2025
Locations: Tekton Research, LLC., McKinney, Texas
Conditions: Type 1 Diabetes, Obesity, Overweight